Medicines Acceptability in Hospitalized Children: An Ongoing Need for Age-Appropriate Formulations

Author:

Vallet ThibaultORCID,Elhamdaoui OmarORCID,Berraho Amina,Cherkaoui Lalla Ouafae,Kriouile Yamna,Mahraoui Chafiq,Mouane Nezha,Pense-Lheritier Anne-Marie,Ruiz FabriceORCID,Bensouda YahyaORCID

Abstract

Although knowledge on medicine acceptability remains fragmented, this multi-faceted concept has emerged as a key factor for compliance in pediatrics. In order to investigate the acceptability of medicines used in the University Medical Centre Ibn Sina (CHIS) of Rabat, Morocco, an observational study was conducted. Using a multivariate approach integrating the many aspects of acceptability, standardized observer reports were collected for 570 medicine intakes in patients up to the age of 16, then analyzed on a reference framework. Tablets appeared to be well accepted in children greater than 6 years old, but were crushed/dissolved for 90% of the 40 children aged from 3 to 5, and 100% of the 38 patients younger than 3. Moreover, the prescribed dose was fully taken for only 52% and 16% of these younger children, respectively. Despite this, tablets represented 24% of evaluations in children from 3 to 5 and 20% in infants and toddlers. Oral liquid preparations appeared to be better accepted than tablets in preschoolers, but not for those under 3. Overall, these findings highlight the lack of suitable alternatives for the younger children, especially for formulations of antiepileptics, antithrombotic, and psycholeptic agents in the local context.

Publisher

MDPI AG

Subject

Pharmaceutical Science

Reference35 articles.

1. Guideline on Pharmaceutical Development of Medicines for Paediatric Use EMA/CHMP/QWP/805880/2012 Rev. 2,2013

2. Medicines for Children: A Matter of Taste

3. Prescribing for children – taste and palatability affect adherence to antibiotics: a review

4. Toolkit for Research and Development of Paediatric Antiretroviral Drugs and Formulations,2018

5. Manipulating tablets and capsules given to hospitalised children in Norway is common practice

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3